SaaS

listed by broker
biotech / pharma
Founded in
2021
Desired valuation:
open to offers
Description
we developed a proprietary patent pending technology to drastically reduce time and cost associated with designing, testing and developing new drugs, nutritional supplements and any protein, peptide and enzyme applications. We are a bootstrapped startup that started with the idea to develop a SaaS platform, but just a couple of months ago we decided to offer our services online. We have a partnership with a worldwide leading platform. We performed a POC with a specialized company. NA
Featured metrics
NA
Selling details
Type of shares
This is some text inside of a div block.
Reason for selling
I want to cash out part of my ownership
Preferred acquirer
acquirer with cash or business angel
Aspirations & growth opportunities
there is a great opportunity to grown in a huge market
Business details
Business model
sell services about proteins/peptides/enzymes and partnerships with biotech companies
Customers
1 (biotech/pharma/cosmetics companies and any business where proteins are involved)
Competition
many companies in the world perform research in the same direction, but no one can offer a deterministic model with exact results. All models available are probabilistic.
Operational details
Technology stack
ReactJS + MySQL
Marketing spend
0 (social media - Direct contacts to research centers and bio-pharma companies)
Performance tracking tools
Stripe
Financial details
Ownership structure
50/50 ownership between the 2 co-founders
Last month's revenue
0
Last month's profit
0
Financial records
Online reporting software/tools
Metrics
TTM revenue
300. We incorporated in November 2021 and started our activity in July 2022
TTM net profit
0
Based in
AMER
Team members
1-2
Acquisition type
Any
Desired valuation
open to offers
Message Owner
627054b1d9afee000403a718
Message Broker
627054b1d9afee000403a718